Filing Manager
Cambridge Equities, LP
Reporting Manager
Patrick Soon-Shiong
Symbol
IBRX
Shares outstanding
1,124,549,707 shares
Disclosed Ownership
745,576,456 shares
Ownership
66%
Form type
SCHEDULE 13D/A
Filing time
25 Feb 2026, 21:51:53 UTC
Date of event
23 Feb 2026
Previous filing
10 Nov 2025

Quoteable Key Fact

"Cambridge Equities, LP disclosed 66% ownership in ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX) on 23 Feb 2026."

Quick Takeaways

  • Cambridge Equities, LP filed SCHEDULE 13D/A for ImmunityBio, Inc. Common Stock, par value $0.0001 per share (IBRX).
  • Disclosed ownership: 66%.
  • Date of event: 23 Feb 2026.

What Changed

  • Previous schedule filing date: 10 Nov 2025.
  • Current filing was accepted on 25 Feb 2026, 21:51.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cambridge Equities, LP 26% 261,705,814 0 261,705,814 /s/ Charles Kenworthy Charles Kenworthy, Manager of MP 13 Ventures, LLC, the General Partner of Cambridge Equities, LP 0001629222
MP 13 Ventures, LLC 26% 261,705,814 0 261,705,814 /s/ Charles Kenworthy Charles Kenworthy, Manager 0001629186
NantWorks, LLC 9.6% 98,535,253 0 98,535,253 /s/ Robert Morse Robert Morse, CFO of NantWorks, LLC 0001675760
Nant Capital, LLC 30% 339,465,529 0 339,465,529 /s/ Charles Kenworthy Charles Kenworthy, Manager of Nant Capital, LLC 0001675758
California Capital Equity, LLC 10% 106,511,412 0 106,511,412 /s/ Charles Kenworthy Charles Kenworthy, Manager of California Capital Equity, LLC 0001517764
Patrick Soon-Shiong 66% 745,576,456 32,275,375 713,301,081 /s/ Patrick Soon-Shiong Patrick Soon-Shiong 0001189020
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .